ArticleCancers2021
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma.
Natasha Carmell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleCancers2021
Natasha Carmell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.